Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this phase III study in subjects with differentiated thyroid cancer (papillary, follicular, Hurthle cell carcinoma) who are refractory to radioactive iodine treatment is to compare the treatment groups in terms of progression free survival (PFS) evaluated by the Response Evaluation Criteria In Solid Tumors (RECIST) criteria.
Inclusion criteria
- Cancer diferenciado de Tiroides Differentiated thyroid cancer